About Sigma-Aldrich (NASDAQ:SIAL)
Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products. Its business unit structure is aligned into three business units: Research, Applied and SAFC Commercial. Its brands include Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. It offers its products and services to research and applied labs, pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies and non-profit organizations, among others. It operates in around 37 countries and sells into approximately 160 countries.
Industry, Sector and Symbol
Industry Specialty Chemicals
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity13.72%
Return on Assets10.47%
Sigma-Aldrich (NASDAQ:SIAL) Frequently Asked Questions
What is Sigma-Aldrich's stock symbol?
Sigma-Aldrich trades on the NASDAQ under the ticker symbol "SIAL."
How were Sigma-Aldrich's earnings last quarter?
Sigma-Aldrich Co. (NASDAQ:SIAL) released its quarterly earnings data on Tuesday, November, 3rd. The specialty chemicals company reported $1.00 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.06 by $0.06. The specialty chemicals company had revenue of $703 million for the quarter, compared to the consensus estimate of $689.97 million. Sigma-Aldrich had a net margin of 16.22% and a return on equity of 13.72%. During the same quarter in the prior year, the firm earned $1.06 EPS. View Sigma-Aldrich's Earnings History.
Who are some of Sigma-Aldrich's key competitors?
Some companies that are related to Sigma-Aldrich include Orica (ORI), Johnson Matthey (JMAT), Croda International (CRDA), Cytec Industries (CYT), Victrex (VCT), Synthomer (SYNT), Elementis (ELM), Ecosynthetix (ECO), Iofina (IOF), Flexible Solutions International (FSI), Graphene Nanochem (GRPH), Bioamber (BIOA), Terravia (TVIAQ), AZ Electronic Materials Group (AZEM), Chemtura (CHMT) and OM Group (OMG).
Has Sigma-Aldrich been receiving favorable news coverage?
Media coverage about SIAL stock has been trending positive on Thursday, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Sigma-Aldrich earned a coverage optimism score of 0.27 on Accern's scale. They also assigned news coverage about the specialty chemicals company an impact score of 44.55 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Sigma-Aldrich?
Shares of SIAL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Sigma-Aldrich?
Sigma-Aldrich's mailing address is 3050 Spruce St, ST. LOUIS, MO 63103-2530, United States. The specialty chemicals company can be reached via phone at +1-314-7715765.
MarketBeat Community Rating for Sigma-Aldrich (SIAL)MarketBeat's community ratings are surveys of what our community members think about Sigma-Aldrich and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sigma-Aldrich (NASDAQ:SIAL) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Sigma-Aldrich (NASDAQ:SIAL) Earnings History and Estimates Chart
Sigma-Aldrich (NASDAQ SIAL) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/3/2015||Q3 15||$1.06||$1.00||$689.97 million||$703.00 million||View||N/A|
|7/30/2015||Q2||$1.12||$1.01||$696.23 million||$697.00 million||View||N/A|
|5/7/2015||Q115||$1.08||$1.06||$685.23 million||$676.00 million||View||N/A|
|2/12/2015||Q414||$1.09||$1.14||$699.50 million||$705.00 million||View||N/A|
|10/23/2014||Q314||$1.06||$1.06||$689.82 million||$5.90 billion||View||N/A|
|7/24/2014||Q214||$1.11||$1.11||$706.14 million||$701.00 million||View||N/A|
|4/24/2014||Q114||$1.03||$1.06||$690.60 million||$689.00 million||View||Listen|
|2/6/2014||Q413||$1.01||$1.02||$675.97 million||$684.00 million||View||Listen|
|10/22/2013||Q313||$0.99||$1.05||$661.29 million||$664.00 million||View||N/A|
|7/23/2013||Q2 2013||$1.04||$1.05||$679.50 million||$681.00 million||View||N/A|
|4/25/2013||Q1 2013||$1.01||$1.03||$672.89 million||$675.00 million||View||N/A|
|2/7/2013||Q4 2012||$0.95||$0.96||$659.55 million||$655.00 million||View||N/A|
Sigma-Aldrich (NASDAQ:SIAL) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Sigma-Aldrich (NASDAQ:SIAL) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Sigma-Aldrich (NASDAQ SIAL) Insider Trading and Institutional Ownership History
Sigma-Aldrich (NASDAQ SIAL) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|10/26/2015||J Pedro Reinhard||Director||Sell||3,000||$139.77||$419,310.00||27,580|| |
|6/17/2015||J Pedro Reinhard||Director||Sell||6,000||$139.35||$836,100.00|| |
|3/11/2015||George Lloyd Miller||SVP||Sell||7,095||$137.89||$978,329.55|| |
|11/5/2014||Lee Mccollum||Director||Sell||10,000||$135.26||$1,352,600.00|| |
|7/28/2014||Karen J Miller||SVP||Sell||7,943||$103.19||$819,638.17|| |
|5/29/2014||Eric Mark Green||EVP||Sell||4,544||$98.03||$445,448.32|| |
|5/28/2014||Gilles Cottier||EVP||Sell||12,000||$98.10||$1,177,200.00|| |
|4/28/2014||Frank Wicks||EVP||Sell||5,443||$95.21||$518,228.03||22,081|| |
|3/4/2014||Douglas Rau||VP||Sell||15,100||$93.53||$1,412,303.00||13,586|| |
|2/24/2014||J Pedro Reinhard||Director||Sell||2,450||$93.52||$229,124.00||27,820|| |
|2/19/2014||Karen Miller||SVP||Sell||1,133||$95.62||$108,337.46||5,009|| |
|2/14/2014||Barrett Toan||Director||Sell||18,000||$96.35||$1,734,300.00||28,773|| |
|2/11/2014||Gilles Cottier||EVP||Sell||28,600||$94.00||$2,688,400.00||22,528|| |
|12/4/2013||Avi Nash||Director||Sell||3,100||$88.00||$272,800.00||15,500|| |
|12/3/2013||Karen Miller||SVP||Sell||7,100||$86.90||$616,990.00||3,457|| |
|11/26/2013||Avi Nash||Director||Sell||10,000||$87.13||$871,300.00||19,100|| |
|9/4/2013||Jan Bertsch||CFO||Buy||1,204||$83.04||$99,980.16||2,704|| |
|9/4/2013||Lee Mccollum||Director||Sell||7,400||$83.44||$617,456.00||12,000|| |
|5/28/2013||Gilles Cottier||EVP||Sell||5,981||$85.30||$510,179.30|| |
|5/22/2013||Gilles Cottier||EVP||Sell||5,319||$85.03||$452,274.57|| |
|5/22/2013||Karen J Miller||SVP||Sell||2,713||$85.00||$230,605.00|| |
|5/15/2013||Eric Mark Green||EVP||Sell||3,900||$83.05||$323,895.00|| |
|2/15/2013||George Lloyd Miller||SVP||Buy||1,000||$76.92||$76,920.00|| |
|11/1/2012||Jan Bertsch||CFO||Buy||1,500||$70.60||$105,900.00|| |
Sigma-Aldrich (NASDAQ SIAL) News Headlines
Sigma-Aldrich (NASDAQ:SIAL) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Sigma-Aldrich (NASDAQ:SIAL) Income Statement, Balance Sheet and Cash Flow Statement
Sigma-Aldrich (NASDAQ SIAL) Stock Chart for Thursday, March, 22, 2018